top of page
Search

Molnupiravir: a promising new treatment for COVID-19

Early studies show molnupiravir to be the first oral medication effective against SARS-CoV-2. Safe at therapeutic levels, its active intracellular form introduces lethal mutations in the virus but does not mutate host cell DNA. Developed at Emory University and marketed by Merck, it is most effective when given early in infection. Wikipedia offers an excellent new summary at https://en.wikipedia.org/wiki/Molnupiravir . If further studies confirm the value of molnupiravir, this will be a valuable addition to the fight against COVID-19. However, the best course remains for all of us and our loved ones to get vaccinated, minimizing our chances to get infected or sick with COVID-19 in the first place.

 
 
 

Recent Posts

See All
7.2026 settings for Zoom

With yet another major update, here is what Google recommends for settings for musicians: To configure Zoom for the best musical performance, you must bypass the platform's default voice-optimization

 
 
 
A Look At Another Part Of Life

A book about death and end-of-life issues may be the least likely book you would choose. And if I had known this was the topic I probably wouldn't have picked it up. But I had heard good things about

 
 
 
Dr. William Foege

Dr. William Foege, former Director of the Centers for Disease Control and Prevention, died Saturday 1/24/26 at age 89. He was Director when I started at CDC in 1978. I have never met a medical colleag

 
 
 

Comments

bottom of page